Fox Run Management’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$325K Buy
+1,914
New +$311K 0.04% 733

Other funds holding BLTE

Fox Run Management's BLTE Position: Q3 2026 in Review

Fox Run Management opened a new position in Belite Bio (BLTE) in Q3 2026: 1,914 shares worth $325K. The stake represents 0.04% of the portfolio and ranks #733 among its holdings.

96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Fox Run Management held 1,914 shares of Belite Bio worth $325K as of Q3 2026.
  • Belite Bio was a new Fox Run Management position in Q3 2026.
  • Belite Bio made up 0.04% of Fox Run Management's portfolio in Q3 2026, its #733 holding.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.